Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

5.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

6.2K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
6.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

5.1K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.7K
1.7K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

6.3K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.3K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

2.0K
2.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of rosuvastatin on risk markers for venous thromboembolism in cancer.

Journal of thrombosis and haemostasis : JTH·2018
Same author

Combined loss of PUMA and p21 accelerates c-MYC-driven lymphoma development considerably less than loss of one allele of p53.

Oncogene·2015
Same author

BCL-2 is dispensable for thrombopoiesis and platelet survival.

Cell death & disease·2015
Same author

Oncogenes and B-lymphocyte neoplasia.

Immunology today·2014
Same author

Loss of Bak enhances lymphocytosis but does not ameliorate thrombocytopaenia in BCL-2 transgenic mice.

Cell death and differentiation·2014
Same author

Pain-releasing action of platelet-activating factor (PAF) antagonists in neuropathic pain animal models and the mechanisms of action.

European journal of pain (London, England)·2013

Related Experiment Video

Updated: Mar 27, 2026

Focus Formation: A Cell-based Assay to Determine the Oncogenic Potential of a Gene
08:18

Focus Formation: A Cell-based Assay to Determine the Oncogenic Potential of a Gene

Published on: December 31, 2014

29.0K

FoxO3 suppresses Myc-driven lymphomagenesis.

C J Vandenberg1,2, N Motoyama3, S Cory1,2

  • 1Molecular Genetics of Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.

Cell Death & Disease
|January 15, 2016
PubMed
Summary

Loss of the FoxO3 transcription factor accelerates cancer development in mouse models. This study reveals FoxO3

More Related Videos

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

8.8K
Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

3.3K

Related Experiment Videos

Last Updated: Mar 27, 2026

Focus Formation: A Cell-based Assay to Determine the Oncogenic Potential of a Gene
08:18

Focus Formation: A Cell-based Assay to Determine the Oncogenic Potential of a Gene

Published on: December 31, 2014

29.0K
Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

8.8K
Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

3.3K

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Transcription factors regulate gene expression and cellular processes.
  • Forkhead box class O (FoxO) proteins are key regulators of stress resistance, metabolism, and cell cycle.
  • Dysregulation of transcription factors, including FoxO, is implicated in various cancers.

Purpose of the Study:

  • To investigate the role of individual FoxO transcription factors in lymphomagenesis.
  • To determine if FoxO3 acts as a tumor suppressor in Myc-driven cancers.
  • To elucidate the mechanisms by which FoxO3 loss impacts cancer progression.

Main Methods:

  • Utilized two distinct transgenic mouse models (vavP-MYC10 and Eμ-myc).
  • Generated mice with targeted deletion of the FoxO3 gene.
  • Performed tumor analysis, including assessment of cell populations and p53 pathway mutations.
  • Conducted in vitro cell culture assays to evaluate cell survival and cell cycling.

Main Results:

  • Loss of a single FoxO transcription factor, FoxO3, promotes lymphomagenesis.
  • FoxO3 deficiency significantly accelerated myeloid and B-lymphoma development in mouse models.
  • Elevated macrophage numbers were observed in FoxO3-deficient mice with myeloid tumors.
  • In vitro studies showed enhanced survival of Myc-driven cancer cells lacking FoxO3.

Conclusions:

  • FoxO3 exhibits significant tumor-suppressor activity in Myc-driven lymphomagenesis.
  • Loss of FoxO3 enhances cancer cell survival, contributing to tumorigenesis.
  • Other FoxO family members (FoxO1/4) may not fully compensate for the loss of FoxO3's tumor-suppressive functions.